Beijing Strong Biotechnologies,Inc. Stock

Equities

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
17.2 CNY -1.88% Intraday chart for Beijing Strong Biotechnologies,Inc. -2.22% -9.95%
Sales 2024 * 2.05B 283M Sales 2025 * 2.43B 336M Capitalization 10.02B 1.38B
Net income 2024 * 619M 85.5M Net income 2025 * 770M 106M EV / Sales 2024 * 4.88 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.12 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
13 x
Employees 1,094
Yield 2024 *
1.41%
Yield 2025 *
1.7%
Free-Float 38.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.88%
1 week-2.22%
Current month-10.88%
1 month-17.03%
3 months-8.02%
6 months-7.18%
Current year-9.95%
More quotes
1 week
16.90
Extreme 16.9
17.87
1 month
16.90
Extreme 16.9
20.62
Current year
16.00
Extreme 16
21.78
1 year
16.00
Extreme 16
24.80
3 years
12.50
Extreme 12.5
25.59
5 years
12.15
Extreme 12.15
25.73
10 years
4.59
Extreme 4.585
41.94
More quotes
Managers TitleAgeSince
Founder 62 01-03-28
Director of Finance/CFO 55 06-12-31
Director/Board Member 47 16-11-30
Members of the board TitleAgeSince
Director/Board Member 73 17-04-17
Director/Board Member 62 20-08-12
Founder 66 01-03-28
More insiders
Date Price Change Volume
24-04-19 17.07 -0.76% 5,622,833
24-04-18 17.2 -1.88% 4,626,441
24-04-17 17.53 +3.18% 5,924,892
24-04-16 16.99 -3.63% 4,739,847
24-04-15 17.63 +1.38% 4,753,635

End-of-day quote Shenzhen S.E., April 17, 2024

More quotes
Beijing Strong Biotechnologies Inc. is a China-based company mainly engaged in the research and development, manufacture and sales of in vitro diagnostic reagents. The Company’s in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The Company is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The Company operates businesses in domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.2
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300406 Stock